Previous 10 | Next 10 |
Purchase Deposits for the New BaroShear K45 System Will be Accepted Immediately; Company Believes Sales into the CBD Market Could Double Current Revenue by Q2 2020 SOUTH EASTON, MA / ACCESSWIRE / June 27, 2019 / Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" or the "Company"), a le...
Pressure BioSciences (OTCQB: PBIO) , a leader in the development and sale of broadly enabling, pressure-based technology and products to the worldwide life sciences industry, this morning announced the first major milestone achievement in its collaboration with the College of Food, Agricultur...
Proprietary, Custom Built UST-Based Instrument Delivered to Collaborators at The Ohio State University; OSU Scientists to Study Pressure and Shear Effects on Pathogen Inactivation, Stability, and Quality SOUTH EASTON, MA / ACCESSWIRE / June 26, 2019 / Pressure BioSciences, Inc. (OTCQB: ...
The cost of foodborne illnesses in the U.S. is estimated at more than $15.6 billion, with one in six Americans falling ill and roughly 3,000 dying from contaminated food and beverages annually High pressure processing plays an important role in food safety and is currently a $20 billion m...
The presentations were held during the annual American Society of Mass Spectrometry conference – an event attended by more than 10,000 scientists Research focused on a wide range of applications ranging from cancer research to biomarker discovery The number of PCT-related present...
Pressure BioSciences (OTCQB: PBIO) today announced the featuring of its HUB platform of unique, ultra-high pressure instruments in three presentations at the world's largest annual food science conference, the Institute of Food Technologists ("IFT"), held in New Orleans, Louisiana, earlier t...
HUB Platform Plays Critical Role in Innovative Research Studies Designed to Increase Understanding of and Develop Methods for the Prevention of Serious Food-Borne Diseases Caused by E. coli and Listeria SOUTH EASTON, MA / ACCESSWIRE / June 19, 2019 / Pressure BioSciences, Inc. (OTCQB: P...
Pressure BioSciences (OTCQB: PBIO) , a leader in the development and sale of high pressure-based instruments, consumables, and related services for the global life sciences and other industries worldwide, today announced its patented pressure cycling technology ("PCT") platform was prominentl...
Scientists from Leading Laboratories in Europe, Asia, Oceania, and North America Highlight the Critical Importance of PBI's Patented PCT System in Cancer and Other Priority Research Areas SOUTH EASTON, MA / ACCESSWIRE / June 12, 2019 / Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" ...
Pressure BioSciences, Inc. (PBIO) Q1 2019 Earnings Conference Call May 16, 2019 4:30 PM ET Company Participants Richard Schumacher - President & Chief Executive Officer Conference Call Participants Geoffrey Scott - Scott Asset Management. Presentation Operator Goo...
News, Short Squeeze, Breakout and More Instantly...
Pressure BioSciences Inc Company Name:
PBIO Stock Symbol:
OTCMKTS Market:
Pressure BioSciences Inc Website:
Pressure BioSciences (OTCQB: PBIO) , a leading innovator in high-pressure nanotechnology and a pioneer in the development of novel, broadly-enabling, pressure-based instruments and nanoemulsion products and services across global industries, today announced a partnership with Vita-Forte, the larg...
CANTON, Mass., June 25, 2024 (GLOBE NEWSWIRE) -- Pressure BioSciences, Inc. (OTCQB: PBIO) (“PBIO” or the “Company”), a leading innovator in high-pressure nanotechnology and a pioneer in the development of novel, broadly-enabling, pressure-based instruments and nanoemul...
Pressure BioSciences (OTCQB: PBIO) , a pioneer in the development and distribution of broadly enabling pressure-based instruments, consumables and specialty process development and testing services across global industries, today announced that it will host a teleconference to update investors an...